First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models

Julie A. Kelly, Noreen T. Boyle, Natalie Cole, Gillian R. Slator, M. Alessandra Colivicchi, Chiara Stefanini, Oliviero L. Gobbo, Gaia A. Scalabrino, Sinead M. Ryan, Marwa Elamin, Cathal Walsh, Alice Vajda, Margaret M. Goggin, Matthew Campbell, Deborah C. Mash, Shane M. O'Mara, David J. Brayden, John J. Callanan, Keith F. Tipton, Laura Della CorteJackie Hunter, Kathy M. O'Boyle, Carvell H. Williams, Orla Hardiman

Research output: Contribution to journalArticle

11 Scopus citations

Fingerprint Dive into the research topics of 'First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models'. Together they form a unique fingerprint.

Medicine & Life Sciences